Gilead clears European hurdle for next-generation hepatitis C drug

European drug gatekeepers Friday blessed Gilead Sciences Inc.'s next-generation hepatitis C combination, the company said...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.